Status:
COMPLETED
Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Brief Summary
Confirmation of safety profile
Eligibility Criteria
Inclusion
- treatment of Ulcerative Colitis
Exclusion
- hypersensitivity to mesalazine
- severe liver or renal impairment
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
568 Patients enrolled
Trial Details
Trial ID
NCT01517594
Start Date
October 1 2011
End Date
June 1 2013
Last Update
October 21 2013
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
FN sv.Anna
Brno, Czechia
2
Gastroenterologická ambulance
Brno, Czechia
3
Hospital Milosrdných bratří
Brno, Czechia
4
Hospital Břeclav
Břeclav, Czechia